Biovie Debt
| BIVI Stock | USD 3.10 0.30 10.71% |
Biovie Inc has over 6.11 Million in debt which may indicate that it relies heavily on debt financing. With a high degree of financial leverage come high-interest payments, which usually reduce Biovie's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Biovie's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Biovie's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Biovie Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Biovie's stakeholders.
For most companies, including Biovie, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Biovie Inc, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Biovie's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Biovie's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Biovie is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Biovie to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Biovie is said to be less leveraged. If creditors hold a majority of Biovie's assets, the Company is said to be highly leveraged.
Biovie |
Biovie Bond Ratings
Biovie Inc financial ratings play a critical role in determining how much Biovie have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Biovie's borrowing costs.| Piotroski F Score | 2 | Frail | View |
| Beneish M Score | (6.05) | Unlikely Manipulator | View |
Biovie Inc Debt to Cash Allocation
As Biovie Inc follows its natural business cycle, the capital allocation decisions will not magically go away. Biovie's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Biovie Inc currently holds 6.11 M in liabilities with Debt to Equity (D/E) ratio of 3.34, implying the company greatly relies on financing operations through barrowing. Biovie Inc has a current ratio of 4.41, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Biovie's use of debt, we should always consider it together with its cash and equity.Biovie Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Biovie's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Biovie, which in turn will lower the firm's financial flexibility.Biovie Corporate Bonds Issued
Most Biovie bonds can be classified according to their maturity, which is the date when Biovie Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understaning Biovie Use of Financial Leverage
Understanding the composition and structure of Biovie's debt gives an idea of how risky is the capital structure of the business and if it is worth investing in it. The degree of Biovie's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets).
BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada. BioVie operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people. Please read more on our technical analysis page.
Currently Active Assets on Macroaxis
When determining whether Biovie Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biovie's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biovie Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biovie Inc Stock:Check out the analysis of Biovie Fundamentals Over Time. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biovie's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.